Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19.
Cabezón Villalba G, Amat-Santos IJ, Dueñas C, Lopez Otero D, Catala P, Aparisi A, López-Pais J, Cacho Antonio CE, Candela J, Antúnez Muiños P, Gil JF, Gonzalez Ferrero T, Marcos M, Pérez-Poza M, Rojas G, Otero Garcia O, Veras C, Jiménez Ramos V, Uribarri A, Revilla A, Garcia-Granja PE, Gómez I, González-Juanatey JR, San Román JA.
Cabezón Villalba G, et al.
Cardiol J. 2021;28(3):360-368. doi: 10.5603/CJ.a2021.0034. Epub 2021 Apr 12.
Cardiol J. 2021.
PMID: 33843043
Free PMC article.